Malaria is the most significant health risk for travellers to Uganda and one of the most straightforward to manage effectively. The combination of chemoprophylaxis (preventive medication), mosquito bite avoidance, and prompt treatment if infection occurs reduces the risk from serious to manageable for the vast majority of visitors. What follows is a practical, evidence-based guide to malaria prevention for people planning a gorilla trekking trip to Uganda—not a substitute for medical consultation, but a foundation for an informed conversation with your travel medicine physician before departure.
Uganda’s malaria risk profile
Uganda has one of the highest rates of malaria transmission in sub-Saharan Africa, with Plasmodium falciparum—the most dangerous malaria species—accounting for the overwhelming majority of cases. Transmission occurs throughout the country and year-round, though risk is somewhat lower at the higher altitudes of southwestern Uganda (Bwindi is at 1,160–2,607 metres, where anopheline mosquito populations are reduced relative to lowland areas). The highlands are not malaria-free—transmission occurs above 1,500 metres with some regularity—but the risk at Bwindi’s elevations is meaningfully lower than in Kampala, the Nile basin lowlands, or Queen Elizabeth National Park. Travellers who combine Bwindi with lower-elevation parks face higher overall exposure. All visitors to Uganda should take chemoprophylaxis regardless of itinerary.
Chemoprophylaxis: the three main options
Three medications are currently recommended for malaria prophylaxis in Uganda: atovaquone-proguanil (Malarone), doxycycline, and mefloquine (Lariam). Each has different dosing schedules, side effect profiles, and contraindications. Atovaquone-proguanil (Malarone) is the most commonly prescribed for Uganda travel: it is taken daily starting two days before entering a malaria zone, continued throughout the trip, and for seven days after leaving. Side effects are generally mild (nausea in some people, best managed by taking with food). It is safe for most adults and children over five kilograms. It is expensive for extended trips (daily dosing adds up over months). Doxycycline is a daily antibiotic that doubles as malaria prophylaxis; it is cheaper than Malarone, effective, and used widely. It causes photosensitivity (increased sunburn risk) and must not be taken during pregnancy. Mefloquine is taken weekly but has a documented rate of neuropsychiatric side effects (vivid dreams, anxiety, depression) that makes it a second-line option for most travel medicine practitioners today. Consult your physician about which is appropriate for your specific health situation, trip length, and budget.
Mosquito bite avoidance: the equally important half
Chemoprophylaxis reduces the risk of malaria infection if bitten but does not prevent bites. Mosquito bite avoidance is a separate and equally important layer of protection. The key measures: wear long-sleeved shirts and long trousers after dusk (when anopheline mosquitoes are most active), use DEET-based repellent on exposed skin (30–50% concentration is effective and durable), sleep under a permethrin-treated bed net (most lodges in Uganda provide nets), and treat clothing and gear with permethrin spray before departure. The anopheline mosquito that transmits malaria bites primarily between dusk and dawn; daytime activity carries very low malaria transmission risk. Travellers who are rigorous about bite avoidance in the evening and at night—long sleeves at sundowner time, repellent applied before dinner, net in use overnight—significantly reduce their exposure even without chemoprophylaxis, though prophylaxis is still recommended as an additional layer.
Recognising malaria symptoms
Malaria symptoms typically appear seven to 30 days after an infective bite, though they can appear up to three months after leaving a malaria zone. The classic presentation is fever—high temperature (38°C or above), often with cyclical chills, sweating, headache, muscle aches, and fatigue. These symptoms are non-specific (they resemble flu) and malaria cannot be diagnosed on symptoms alone—a blood test (rapid diagnostic test or microscopy) is required for confirmation. Any traveller developing fever during travel in Uganda or within three months of return should seek medical attention immediately and inform the healthcare provider of their recent travel history. Falciparum malaria, if untreated, can progress to severe malaria within 24 to 48 hours—affecting the brain, kidneys, and blood. The window for effective treatment is short; seeking care at first symptoms is not an overreaction.
Standby emergency treatment (SBET)
For travellers to remote areas where medical care is not readily accessible—which describes Bwindi’s location relative to Kampala—some travel medicine physicians prescribe a standby emergency treatment course (typically artemether-lumefantrine, sold as Coartem) to carry and use if malaria is strongly suspected and medical care cannot be reached within 24 hours. SBET is not a substitute for medical diagnosis—it should be used only when symptoms are consistent with malaria and professional care is genuinely inaccessible—but it provides a critical safety net for travellers who develop high fever in a remote location. Discuss SBET with your travel medicine physician if your itinerary includes extended time in areas more than two hours from a functioning laboratory.
The Bwindi altitude question
A common question from travellers who have read that malaria transmission decreases with altitude: is Bwindi safe without prophylaxis? The answer is no. While the risk at Bwindi’s elevations is lower than in Uganda’s lowlands, it is not zero—local case data confirm malaria transmission above 1,500 metres in the Kigezi highlands. More practically, most Uganda itineraries involve at least one night in Kampala (1,300 metres, significant malaria risk) and often include lower-elevation parks (Queen Elizabeth, Murchison Falls) where risk is high. Taking prophylaxis for the highland Bwindi portion only and not for the rest of the trip is logistically complicated and epidemiologically insufficient. Take prophylaxis for the entire trip; the incremental cost and inconvenience are negligible relative to the protection provided.
Children and malaria prevention
Malaria in children can progress more rapidly than in adults, and the symptoms can be less specific—general irritability and reduced appetite may precede the classic fever. Atovaquone-proguanil (Malarone) is approved for children above 5 kilograms and is available in paediatric tablet formulations. Doxycycline is not appropriate for children under eight. Bite avoidance measures—permethrin-treated nets, DEET repellent (applied by adults, not children themselves, and avoiding eyes and hands), long-sleeved clothing at dusk—are especially important for children who may not tolerate medications as well as adults. Any child developing fever during or after Uganda travel should be assessed for malaria promptly; do not wait for multiple symptom cycles to confirm before seeking care.
Before you leave: the travel medicine consultation
The most important malaria prevention step happens before departure: a consultation with a travel medicine physician or clinic that can review your full health history, prescribe the appropriate prophylactic medication, and address any other health risks relevant to your itinerary. In addition to malaria, travel medicine consultations for Uganda should address yellow fever vaccination (required for entry), typhoid and hepatitis A (food and water precautions), rabies pre-exposure prophylaxis (relevant given wildlife contact), and any destination-specific considerations based on your health history. Plan this consultation four to six weeks before departure to allow time for vaccinations that require multiple doses and for chemoprophylaxis to be sourced if not readily available at local pharmacies. Preparation is the best medicine.
